PDT Partners’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-26,804
Closed -$372K – 963
2022
Q3
$372K Sell
26,804
-20,418
-43% -$303K 0.06% 524
2022
Q2
$678K Buy
47,222
+28,920
+158% +$502K 0.06% 516
2022
Q1
$414K Buy
18,302
+5,588
+44% +$108K 0.04% 634
2021
Q4
$239K Buy
+12,714
New +$339K 0.02% 734
2021
Q2
– Sell
-9,647
Closed -$370K – 993
2021
Q1
$370K Buy
9,647
+43
+0.4% +$1.83K 0.03% 560
2020
Q4
$420K Buy
+9,604
New +$361K 0.03% 478
2019
Q2
– Sell
-24,400
Closed -$943K – 482
2019
Q1
$943K Hold
24,400
– – 0.05% 267
2018
Q4
$695K Sell
24,400
-9
-0% -$286 0.04% 300
2018
Q3
$955K Sell
24,409
-2,819
-10% -$104K 0.04% 313
2018
Q2
$881K Buy
+27,228
New +$749K 0.03% 346
2015
Q3
– Sell
-34,536
Closed -$913K – 1648
2015
Q2
$913K Buy
34,536
+10,857
+46% +$351K 0.02% 773
2015
Q1
$924K Buy
+23,679
New +$816K 0.02% 819
2014
Q4
– Sell
-8,680
Closed -$205K – 1177
2014
Q3
$205K Buy
+8,680
New +$247K 0.01% 1183
2014
Q2
– Sell
-17,311
Closed -$550K – 1706
2014
Q1
$550K Buy
+17,311
New +$572K 0.01% 901

Other funds holding CSII

PDT Partners's CSII Position: Q4 2022 in Review

PDT Partners sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2022, closing a stake of 26,804 shares — an estimated $372K sold.

PDT Partners first reported a position in CSII in Q1 2014 and held it in 14 quarters. The position peaked at $955K in Q3 2018. 161 funds tracked by Wall St. Rank hold CSII as of Q4 2022.

  • PDT Partners reported no remaining Cardiovascular Systems, Inc. position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 26,804 Cardiovascular Systems, Inc. shares in Q4 2022, an estimated $372K.
  • PDT Partners first reported a position in Cardiovascular Systems, Inc. in Q1 2014 and held it in 14 quarters.
  • PDT Partners's Cardiovascular Systems, Inc. position peaked at $955K in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.